— Know what they know.
Not Investment Advice

BBBT OTC

Black Bird Biotech, Inc.
1W: +0.0% 1M: +0.0% 3M: +9900.0% YTD: +0.0% 1Y: +0.0% 3Y: -50.0% 5Y: -99.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 46 · $98405 mcap · 983M float · 0.188% daily turnover · Short 9% of daily vol

Cash Flow Trends

Operating Cash Flow
-$1M -4.0% ▼
Capital Expenditures
$4 +100.1% ▲
Free Cash Flow
-$1M -3.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$455K -201.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$121K-$122K-$690K-$2M-$2M
Depreciation & Amort.$0$0$0$110K$89K
Stock-Based Comp.$0$45K$23K$573K$34
Change in Working Capital$45K$36K$13K-$131K$167K
Other Non-Cash Items$0-$45K$35K$840K$370K
Operating Cash Flow-$76K-$86K-$619K-$992K-$1M
— Investing Activities —
Capital Expenditures$0$0$0-$6K$4
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0-$20K-$180K-$4
Investing Cash Flow$0$0-$20K-$186K$0
— Financing Activities —
Net Debt Issuance$79K$0$84K-$86K$503K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$83K-$8K$0$74K
Financing Cash Flow$79K$83K$606K$2M$577K
Net Change in Cash$3K-$4K-$33K$447K-$455K
Cash End of Period$5K$973$53K$500K$44K
Free Cash Flow-$76K-$86K-$619K-$998K-$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms